CD4 and neoplasm: Additionally, due to the lack of IFN-γ inducible expression of class II transactivator (cIITA), MHC class II molecule expression is absent in SCLC cells and significantly lower in SCLC TILs compared with in NSCLC, resulting in reduced presentation of tumor neoantigens to CD4+ T cells.